Healthcare Realty Trust Key Executives
This section highlights Healthcare Realty Trust's key executives, including their titles and compensation details.
Find Contacts at Healthcare Realty Trust
(Showing 0 of )
Healthcare Realty Trust Earnings
This section highlights Healthcare Realty Trust's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-19 | $0.39 | $0.40 |
| Read Transcript | Q3 | 2024 | 2024-10-30 | $0.38 | $0.39 |
| Read Transcript | Q2 | 2024 | 2024-08-02 | $0.38 | $0.38 |
| Read Transcript | Q1 | 2024 | 2024-05-07 | $0.38 | $0.39 |
| Read Transcript | Q4 | 2023 | 2024-02-16 | $0.40 | $0.39 |
| Read Transcript | Q3 | 2023 | 2023-11-03 | $0.39 | $0.39 |
| Read Transcript | Q2 | 2023 | 2023-08-08 | $0.40 | $0.39 |
| Read Transcript | Q1 | 2023 | 2023-05-09 | $0.41 | $0.40 |
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2020, the Company owned 211 real estate properties in 24 states totaling 15.5 million square feet and was valued at approximately $5.5 billion. The Company provided leasing and property management services to 11.9 million square feet nationwide.
$16.76
Stock Price
$5.88B
Market Cap
550
Employees
Nashville, TN
Location
Financial Statements
Access annual & quarterly financial statements for Healthcare Realty Trust, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $1.23B | $1.34B | $932.64M | $534.82M | $499.63M |
| Cost of Revenue | $476.57M | $1.23B | $344.04M | $212.27M | $196.51M |
| Gross Profit | $756.21M | $112.62M | $588.60M | $322.54M | $303.12M |
| Gross Profit Ratio | 61.34% | 8.40% | 63.11% | 60.30% | 60.67% |
| Research and Development Expenses | $- | $- | $0 | $0 | $0 |
| General and Administrative Expenses | $83.12M | $58.41M | $52.73M | $34.15M | $30.70M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $83.12M | $58.41M | $52.73M | $34.15M | $30.70M |
| Other Expenses | $- | $- | $453.08M | $202.71M | $190.44M |
| Operating Expenses | $83.12M | $843.33M | $505.82M | $236.87M | $221.14M |
| Cost and Expenses | $559.69M | $1.29B | $849.85M | $449.14M | $417.65M |
| Interest Income | $-5.36M | $-4.84M | $11.48M | $53.13M | $559.00K |
| Interest Expense | $237.13M | $247.99M | $139.92M | $53.13M | $53.47M |
| Depreciation and Amortization | $722.32M | $730.71M | $853.91M | $449.14M | $665.34M |
| EBITDA | $295.55M | $780.51M | $555.62M | $287.60M | $274.18M |
| EBITDA Ratio | 23.97% | 58.08% | 59.57% | 53.77% | 54.88% |
| Operating Income | $673.09M | $54.22M | $77.84M | $84.88M | $79.37M |
| Operating Income Ratio | 54.60% | 4.03% | 8.35% | 15.87% | 15.89% |
| Total Other Income Expenses Net | $-1.33B | $-336.30M | $-42.09M | $-19.02M | $2.46M |
| Income Before Tax | $-654.49M | $-282.08M | $40.69M | $66.66M | $72.19M |
| Income Before Tax Ratio | -53.09% | -20.99% | 4.36% | 12.46% | 14.45% |
| Income Tax Expense | $- | $- | $146.69M | $52.34M | $53.01M |
| Net Income | $-654.49M | $-278.26M | $-106.00M | $14.32M | $19.19M |
| Net Income Ratio | -53.09% | -20.71% | -11.37% | 2.68% | 3.84% |
| EPS | $-1.79 | $-0.74 | $-0.42 | $0.10 | $0.09 |
| EPS Diluted | $-1.79 | $-0.74 | $-0.42 | $0.10 | $0.09 |
| Weighted Average Shares Outstanding | 365.55M | 378.93M | 252.36M | 142.64M | 218.08M |
| Weighted Average Shares Outstanding Diluted | 365.55M | 378.93M | 253.87M | 142.71M | 221.67M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $290.61M | $315.42M | $316.32M | $326.81M | $330.44M | $342.26M | $338.14M | $332.93M | $338.06M | $306.35M | $145.33M | $142.89M | $136.42M | $136.63M | $131.42M | $130.34M | $125.88M | $125.25M | $123.69M | $124.81M |
| Cost of Revenue | $114.41M | $120.23M | $291.20M | $121.08M | $301.41M | $131.64M | $125.39M | $122.04M | $117.09M | $112.47M | $57.01M | $57.46M | $53.03M | $55.52M | $51.51M | $52.22M | $50.21M | $50.17M | $46.58M | $49.55M |
| Gross Profit | $176.19M | $195.19M | $25.13M | $205.73M | $29.03M | $210.62M | $212.75M | $210.88M | $220.97M | $193.88M | $88.32M | $85.43M | $83.39M | $81.11M | $79.91M | $78.12M | $75.67M | $75.08M | $77.11M | $75.25M |
| Gross Profit Ratio | 60.63% | 61.90% | 7.90% | 63.00% | 8.80% | 61.50% | 62.90% | 63.30% | 65.40% | 63.30% | 60.80% | 59.80% | 61.10% | 59.40% | 60.80% | 59.90% | 60.11% | 59.94% | 62.34% | 60.30% |
| Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $34.21M | $20.12M | $14.00M | $14.79M | $14.61M | $13.40M | $15.46M | $14.94M | $14.42M | $16.74M | $10.54M | $11.04M | $8.90M | $8.21M | $8.54M | $8.50M | $7.21M | $7.30M | $7.43M | $8.77M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $34.21M | $20.12M | $14.00M | $14.79M | $14.61M | $13.40M | $15.46M | $14.94M | $14.42M | $16.74M | $10.54M | $11.04M | $8.90M | $8.21M | $8.54M | $8.50M | $7.21M | $7.30M | $7.43M | $8.77M |
| Other Expenses | $141.99M | $- | $173.48M | $-14.96M | $-15.61M | $-14.38M | $-16.46M | $184.48M | $185.19M | $158.12M | $- | $54.04M | $-151.03M | $76.06M | $74.98M | $-10.66M | $- | $- | $- | $- |
| Operating Expenses | $176.19M | $195.19M | $187.48M | $192.91M | $15.61M | $196.38M | $198.66M | $199.41M | $199.61M | $174.86M | $66.27M | $65.08M | $60.71M | $59.21M | $58.37M | $58.58M | $55.31M | $54.44M | $55.12M | $56.26M |
| Cost and Expenses | $290.61M | $303.58M | $305.20M | $313.98M | $317.02M | $328.02M | $324.05M | $321.45M | $316.70M | $287.33M | $123.28M | $122.54M | $113.74M | $114.72M | $109.88M | $110.79M | $105.52M | $104.61M | $101.70M | $105.81M |
| Interest Income | $-1.62M | $-1.27M | $3.87M | $275.00K | $65.00K | $139.00K | $592.00K | $547.00K | $8.11M | $3.37M | $- | $- | $- | $- | $121.00K | $500.00K | $334.00K | $8.00K | $134.00K | $82.00K |
| Interest Expense | $57.12M | $59.41M | $61.37M | $58.62M | $67.69M | $63.98M | $62.77M | $63.76M | $63.73M | $49.25M | $- | $- | $- | $- | $12.57M | $12.32M | $13.64M | $13.23M | $13.52M | $13.09M |
| Depreciation and Amortization | $172.44M | $163.23M | $173.48M | $178.12M | $180.05M | $182.99M | $183.19M | $184.48M | $185.28M | $158.12M | $55.73M | $75.39M | $76.53M | $76.06M | $74.98M | $76.27M | $49.08M | $48.04M | $48.71M | $48.99M |
| EBITDA | $121.36M | $175.07M | $100.47M | $200.48M | $193.47M | $196.24M | $196.29M | $194.52M | $219.91M | $183.98M | $77.78M | $121.93M | $116.14M | $77.49M | $97.08M | $98.27M | $68.23M | $68.17M | $70.15M | $67.22M |
| EBITDA Ratio | 41.76% | 55.50% | 58.36% | 61.34% | 58.55% | 60.18% | 61.69% | 58.79% | 65.05% | 60.06% | 53.32% | 51.96% | 54.32% | 53.24% | 54.16% | 53.65% | 55.08% | 54.10% | 56.52% | 53.83% |
| Operating Income | $- | $11.84M | $11.12M | $201.92M | $13.42M | $201.02M | $241.11M | $11.24M | $21.89M | $16.67M | $20.39M | $19.01M | $39.92M | $44.87M | $45.30M | $45.08M | $44.50M | $43.52M | $37.56M | $39.73M |
| Operating Income Ratio | 0.00% | 3.75% | 3.52% | 61.79% | 4.06% | 58.73% | 71.30% | 3.38% | 6.48% | 5.44% | 14.03% | 13.30% | 29.26% | 32.84% | 34.47% | 34.59% | 35.35% | 34.74% | 30.36% | 31.83% |
| Total Other Income Expenses Net | $-108.21M | $-106.38M | $-157.06M | $-328.04M | $-55.10M | $-82.84M | $-97.82M | $-99.55M | $-57.64M | $-147.72M | $-15.92M | $-30.52M | $-1.07M | $-1.43M | $995.00K | $2.02M | $-60.37M | $-12.03M | $6.42M | $4.07M |
| Income Before Tax | $-108.21M | $-94.53M | $-145.94M | $-315.22M | $-41.67M | $-68.60M | $-83.73M | $-88.08M | $-36.28M | $28.62M | $6.13M | $42.23M | $21.61M | $-2.07M | $23.10M | $24.02M | $-15.86M | $8.23M | $75.51M | $4.32M |
| Income Before Tax Ratio | -37.24% | -29.97% | -46.14% | -96.46% | -12.61% | -20.04% | -24.76% | -26.46% | -10.73% | 9.34% | 4.22% | 29.55% | 15.84% | -1.51% | 17.57% | 18.43% | -12.60% | 6.57% | 61.05% | 3.46% |
| Income Tax Expense | $- | $- | $273.56M | $53.82M | $-159.16M | $62.76M | $61.79M | $34.60M | $55.51M | $53.04M | $13.89M | $23.94M | $23.31M | $12.18M | $12.43M | $12.24M | $-438.00K | $13.23M | $13.52M | $13.09M |
| Net Income | $-106.85M | $-93.02M | $-145.41M | $-310.84M | $-41.90M | $-67.84M | $-82.76M | $-122.68M | $-91.79M | $-24.43M | $6.13M | $18.29M | $21.61M | $-2.07M | $23.10M | $24.02M | $-15.86M | $8.23M | $75.51M | $4.32M |
| Net Income Ratio | -36.77% | -29.49% | -45.97% | -95.11% | -12.68% | -19.82% | -24.47% | -36.85% | -27.15% | -7.97% | 4.22% | 12.80% | 15.84% | -1.51% | 17.57% | 18.43% | -12.60% | 6.57% | 61.05% | 3.46% |
| EPS | $-0.31 | $-0.26 | $-0.39 | $-0.82 | $-0.11 | $-0.18 | $-0.22 | $-0.32 | $-0.24 | $-0.07 | $0.04 | $0.12 | $0.14 | $-0.01 | $0.16 | $0.17 | $-0.07 | $0.06 | $0.56 | $0.03 |
| EPS Diluted | $-0.31 | $-0.26 | $-0.39 | $-0.82 | $-0.11 | $-0.18 | $-0.22 | $-0.32 | $-0.24 | $-0.07 | $0.04 | $0.12 | $0.14 | $-0.01 | $0.16 | $0.17 | $-0.07 | $0.06 | $0.56 | $0.03 |
| Weighted Average Shares Outstanding | 351.56M | 358.96M | 372.48M | 379.45M | 379.04M | 378.93M | 378.90M | 378.84M | 380.59M | 328.81M | 149.68M | 148.96M | 145.95M | 143.82M | 141.92M | 138.77M | 218.57M | 134.31M | 133.63M | 133.04M |
| Weighted Average Shares Outstanding Diluted | 351.56M | 358.96M | 372.48M | 379.45M | 379.04M | 378.93M | 378.90M | 378.84M | 380.59M | 332.03M | 149.74M | 149.05M | 146.04M | 143.82M | 142.05M | 138.87M | 222.10M | 134.36M | 133.70M | 133.15M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $68.92M | $25.70M | $60.96M | $13.18M | $15.30M |
| Short Term Investments | $- | $- | $120.24M | $- | $- |
| Cash and Short Term Investments | $68.92M | $25.70M | $60.96M | $13.18M | $15.30M |
| Net Receivables | $- | $353.68M | $243.18M | $84.86M | $78.20M |
| Inventory | $- | $- | $1 | $13.19M | $39.71M |
| Other Current Assets | $12.90M | $116.45M | $100.79M | $58.67M | $70.55M |
| Total Current Assets | $68.92M | $504.67M | $404.93M | $13.23M | $35.95M |
| Property Plant Equipment Net | $261.44M | $275.98M | $336.98M | $128.39M | $144.87M |
| Goodwill | $631.63M | $250.53M | $223.20M | $3.50M | $3.50M |
| Intangible Assets | $33.24M | $67.76M | $81.84M | $6.20M | $628.62M |
| Goodwill and Intangible Assets | $664.87M | $318.29M | $305.04M | $9.70M | $628.62M |
| Long Term Investments | $- | $319.63M | $335.09M | $161.94M | $73.14M |
| Tax Assets | $- | $-10.69B | $13.85B | $3.76B | $-628.62M |
| Other Non-Current Assets | $9.20B | $531.12M | $-1.38B | $189.16M | $3.56B |
| Total Non-Current Assets | $10.13B | $1.45B | $13.44B | $4.25B | $3.78B |
| Other Assets | $456.94M | $10.69B | $- | $- | $- |
| Total Assets | $10.65B | $12.64B | $13.85B | $4.26B | $3.81B |
| Account Payables | $- | $211.99M | $57.35M | $17.04M | $81.17M |
| Short Term Debt | $296.85M | $364.24M | $4.27M | $- | $- |
| Tax Payables | $- | $- | $78.19M | $35.30M | $- |
| Deferred Revenue | $- | $- | $87.33M | $45.13M | $-13.17M |
| Other Current Liabilities | $- | $-14.15M | $453.78M | $-11.06M | $1.22M |
| Total Current Liabilities | $296.85M | $562.09M | $680.91M | $86.40M | $82.39M |
| Long Term Debt | $- | $4.93B | $5.36B | $1.92B | $1.71B |
| Deferred Revenue Non-Current | $- | $- | $87.33M | $45.13M | $3.56B |
| Deferred Tax Liabilities Non-Current | $- | $- | $-87.33M | $-45.13M | $230.91M |
| Other Non-Current Liabilities | $5.12B | $221.30M | $133.36M | $61.47M | $54.44M |
| Total Non-Current Liabilities | $5.12B | $5.16B | $5.49B | $1.99B | $1.78B |
| Other Liabilities | $-73.05M | $-3.87M | $- | $- | $- |
| Total Liabilities | $5.35B | $5.71B | $6.17B | $2.07B | $1.86B |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $377.81M | $3.81M | $3.81M | $1.50M | $1.40M |
| Retained Earnings | $374.31M | $1.03B | $-2.02B | $-1.78B | $-1.67B |
| Accumulated Other Comprehensive Income Loss | $-1.17M | $-10.74M | $2.14M | $-9.98M | $-17.83M |
| Other Total Stockholders Equity | $4.48B | $5.80B | $9.59B | $5.75B | $5.31B |
| Total Stockholders Equity | $5.23B | $6.82B | $7.57B | $2.19B | $1.95B |
| Total Equity | $5.24B | $6.92B | $7.68B | $2.27B | $2.01B |
| Total Liabilities and Stockholders Equity | $10.65B | $12.64B | $13.85B | $4.26B | $3.81B |
| Minority Interest | $4.78M | $100.12M | $108.74M | $86.71M | $60.68M |
| Total Liabilities and Total Equity | $10.65B | $12.64B | $13.85B | $4.26B | $3.81B |
| Total Investments | $477.23M | $319.63M | $14.06B | $161.94M | $73.14M |
| Total Debt | $296.85M | $5.30B | $5.70B | $1.92B | $1.71B |
| Net Debt | $227.93M | $5.27B | $5.64B | $1.91B | $1.70B |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $68.92M | $22.80M | $41.77M | $26.17M | $25.70M | $24.67M | $35.90M | $49.94M | $60.96M | $57.58M | $34.31M | $22.69M | $13.18M | $16.00M | $18.74M | $12.09M | $15.30M | $121.99M | $43.68M | $103.37M |
| Short Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $120.24M | $118.92M | $2.52M | $-148.74M | $6.17B | $6.11B | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $68.92M | $22.80M | $41.77M | $26.17M | $25.70M | $24.67M | $35.90M | $49.94M | $60.96M | $57.58M | $34.31M | $22.69M | $13.18M | $16.00M | $18.74M | $12.09M | $15.30M | $121.99M | $43.68M | $103.37M |
| Net Receivables | $289.09M | $- | $- | $- | $353.68M | $- | $- | $300.89M | $243.18M | $200.44M | $- | $- | $84.86M | $- | $- | $- | $78.20M | $- | $- | $- |
| Inventory | $- | $- | $- | $- | $- | $- | $- | $- | $1 | $- | $- | $-383.03M | $200.52M | $5.73B | $-382.78M | $-273.35M | $-280.55M | $-208.18M | $-283.25M | $-291.51M |
| Other Current Assets | $167.85M | $156.34M | $34.53M | $30.97M | $125.29M | $57.64M | $151.00K | $92.27M | $100.79M | $185.07M | $- | $14.96M | $58.67M | $13.60M | $21.07M | $64.58M | $70.55M | $80.69M | $- | $20.00K |
| Total Current Assets | $525.86M | $179.02M | $76.30M | $57.14M | $504.67M | $82.31M | $36.05M | $53.52M | $404.93M | $528.14M | $34.31M | $37.66M | $13.23M | $29.60M | $39.80M | $76.67M | $35.95M | $202.69M | $43.68M | $103.39M |
| Property Plant Equipment Net | $261.44M | $336.74M | $261.98M | $273.95M | $275.98M | $323.76M | $333.22M | $336.11M | $336.98M | $321.37M | $126.20M | $126.85M | $128.39M | $149.71M | $140.74M | $140.45M | $144.87M | $143.58M | $144.28M | $137.66M |
| Goodwill | $- | $- | $- | $- | $250.53M | $250.53M | $250.53M | $260.82M | $223.20M | $148.89M | $- | $- | $3.50M | $- | $- | $- | $3.50M | $- | $- | $- |
| Intangible Assets | $33.24M | $718.34M | $764.73M | $816.30M | $67.76M | $890.27M | $922.03M | $86.21M | $81.84M | $87.54M | $4.67B | $403.77M | $6.20M | $515.39M | $626.58M | $627.30M | $639.07M | $629.56M | $640.69M | $642.58M |
| Goodwill and Intangible Assets | $33.24M | $718.34M | $764.73M | $816.30M | $318.29M | $250.53M | $250.53M | $347.03M | $305.04M | $236.44M | $4.67B | $403.77M | $9.70M | $515.39M | $626.58M | $627.30M | $639.07M | $629.56M | $640.69M | $642.58M |
| Long Term Investments | $477.23M | $- | $374.84M | $309.75M | $322.16M | $325.45M | $327.25M | $327.75M | $335.09M | $329.58M | $210.78M | $211.19M | $161.94M | $122.34M | $117.94M | $83.94M | $73.14M | $64.76M | $244.38M | $65.53M |
| Tax Assets | $- | $- | $10.29B | $10.22B | $11.05B | $11.55B | $11.90B | $- | $- | $- | $-4.67B | $- | $3.76B | $3.07B | $2.86B | $2.74B | $2.74B | $2.49B | $2.48B | $2.61B |
| Other Non-Current Assets | $9.35B | $10.01B | $34.53M | $605.05M | $167.00M | $571.55M | $547.27M | $12.50B | $12.47B | $12.78B | $-495.45M | $3.63B | $189.16M | $186.33M | $182.12M | $182.04M | $176.12M | $182.44M | $183.62M | $189.71M |
| Total Non-Current Assets | $10.13B | $11.07B | $11.73B | $12.22B | $12.13B | $13.02B | $13.36B | $13.52B | $13.44B | $13.67B | $4.51B | $4.37B | $4.25B | $4.04B | $3.92B | $3.78B | $3.78B | $3.51B | $3.69B | $3.64B |
| Other Assets | $- | $121.70K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $10.65B | $11.24B | $11.80B | $12.28B | $12.64B | $13.10B | $13.39B | $13.57B | $13.85B | $14.20B | $4.55B | $4.41B | $4.26B | $4.07B | $3.96B | $3.85B | $3.81B | $3.71B | $3.73B | $3.75B |
| Account Payables | $- | $- | $195.88M | $163.17M | $211.99M | $204.95M | $196.15M | $35.13M | $57.35M | $62.77M | $84.21M | $69.13M | $17.04M | $79.38M | $74.93M | $66.41M | $81.17M | $79.53M | $65.48M | $64.57M |
| Short Term Debt | $- | $305.56M | $305.80M | $120.00M | $2.18M | $236.00M | $354.00M | $-42.35M | $4.27M | $-40.49M | $490.50M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $48.63M | $78.19M | $88.88M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $-195.88M | $-163.17M | $-211.99M | $-204.95M | $-196.15M | $90.98M | $87.33M | $60.67M | $-2.85M | $-69.13M | $-17.04M | $-79.38M | $-74.93M | $-66.41M | $-94.35M | $-93.99M | $-65.48M | $-64.57M |
| Other Current Liabilities | $223.79M | $-3.75M | $-195.88M | $700.00K | $90.04M | $-93.54M | $-198.04M | $-953.47M | $453.78M | $-61.70M | $-417.77M | $334.69M | $24.24M | $91.27M | $13.94M | $8.34M | $1.22M | $548.00K | $- | $215.07M |
| Total Current Liabilities | $223.79M | $301.81M | $447.69M | $283.87M | $562.09M | $444.76M | $550.37M | $155.49M | $680.91M | $492.94M | $574.71M | $403.82M | $86.40M | $170.65M | $88.87M | $74.75M | $82.39M | $80.08M | $65.48M | $279.65M |
| Long Term Debt | $4.96B | $5.03B | $5.45B | $5.28B | $4.93B | $5.34B | $5.33B | $5.70B | $5.36B | $5.91B | $1.73B | $2.06B | $1.92B | $1.81B | $1.72B | $1.72B | $1.71B | $1.66B | $1.66B | $1.75B |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $90.98M | $87.33M | $60.67M | $- | $- | $- | $- | $- | $- | $- | $56.26M | $52.66M | $49.90M |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $-90.98M | $-87.33M | $-60.67M | $- | $- | $- | $- | $- | $- | $- | $-56.26M | $-52.66M | $-49.90M |
| Other Non-Current Liabilities | $161.64M | $313.14M | $76.11M | $314.79M | $475.30M | $308.72M | $426.26M | $47.37M | $133.36M | $108.01M | $483.87M | $63.49M | $61.47M | $57.71M | $58.10M | $58.98M | $54.44M | $51.98M | $56.98M | $55.40M |
| Total Non-Current Liabilities | $5.12B | $5.34B | $5.38B | $5.49B | $5.16B | $5.55B | $5.56B | $5.95B | $5.49B | $5.86B | $1.80B | $1.79B | $1.99B | $1.78B | $1.78B | $1.78B | $1.78B | $1.73B | $1.74B | $1.61B |
| Other Liabilities | $- | $- | $- | $- | $-3.87M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $5.35B | $5.65B | $5.83B | $5.77B | $5.71B | $5.99B | $6.11B | $6.10B | $6.17B | $6.36B | $2.37B | $2.20B | $2.07B | $1.95B | $1.87B | $1.86B | $1.86B | $1.81B | $1.80B | $1.89B |
| Preferred Stock | $- | $- | $4.04B | $3.92B | $- | $3.68B | $3.57B | $- | $- | $- | $1 | $- | $623.85M | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $3.50M | $3.56M | $3.64M | $3.81M | $3.81M | $3.81M | $3.81M | $3.81M | $3.81M | $3.81M | $1.52M | $1.52M | $1.50M | $1.48M | $1.46M | $1.42M | $1.40M | $1.36M | $1.36M | $1.35M |
| Retained Earnings | $374.31M | $481.15M | $-3.46B | $-3.20B | $-2.77B | $-2.61B | $-2.43B | $-2.23B | $-2.02B | $-1.87B | $-1.82B | $-1.78B | $-1.78B | $-1.76B | $-1.71B | $-1.69B | $-1.67B | $-1.61B | $-1.58B | $-1.62B |
| Accumulated Other Comprehensive Income Loss | $-1.17M | $-16.96M | $6.99M | $4.79M | $-10.74M | $17.08M | $9.33M | $-8.55M | $2.14M | $5.52M | $-1.25M | $-3.74M | $-9.98M | $-12.41M | $-13.58M | $-13.89M | $-17.83M | $-19.27M | $-20.29M | $-19.78M |
| Other Total Stockholders Equity | $4.86B | $5.05B | $9.34B | $12.81B | $9.60B | $9.60B | $9.60B | $9.59B | $11.61B | $9.59B | $4.00B | $5.78B | $5.75B | $5.64B | $5.53B | $5.39B | $5.31B | $5.15B | $5.11B | $5.11B |
| Total Stockholders Equity | $5.23B | $5.52B | $5.89B | $6.42B | $6.82B | $7.00B | $7.18B | $7.36B | $7.57B | $7.73B | $2.18B | $2.21B | $2.19B | $2.12B | $2.10B | $2.00B | $1.95B | $1.90B | $1.93B | $1.86B |
| Total Equity | $5.31B | $5.60B | $5.97B | $6.51B | $6.92B | $7.11B | $7.29B | $7.47B | $7.68B | $7.84B | $2.18B | $2.30B | $2.27B | $2.21B | $2.16B | $2.06B | $1.95B | $1.96B | $1.99B | $1.92B |
| Total Liabilities and Stockholders Equity | $10.65B | $11.24B | $11.80B | $12.28B | $12.64B | $13.10B | $13.39B | $13.57B | $13.85B | $14.20B | $4.55B | $4.41B | $4.26B | $4.07B | $3.96B | $3.85B | $3.81B | $3.71B | $3.73B | $3.75B |
| Minority Interest | $71.01M | $83.92M | $87.55M | $91.12M | $100.12M | $105.08M | $106.50M | $108.21M | $108.74M | $111.81M | $- | $83.67M | $86.71M | $93.17M | $58.83M | $59.65M | $- | $61.96M | $63.98M | $64.67M |
| Total Liabilities and Total Equity | $10.65B | $11.24B | $11.80B | $12.28B | $12.64B | $13.10B | $13.39B | $13.57B | $13.85B | $14.20B | $4.55B | $4.41B | $4.26B | $4.07B | $3.96B | $3.85B | $3.81B | $3.71B | $3.73B | $3.75B |
| Total Investments | $477.23M | $417.08M | $374.84M | $309.75M | $322.16M | $325.45M | $327.25M | $327.75M | $14.06B | $448.50M | $213.30M | $62.45M | $6.17B | $6.18B | $117.94M | $83.94M | $73.14M | $64.76M | $244.38M | $65.53M |
| Total Debt | $4.96B | $5.26B | $5.45B | $5.41B | $5.30B | $5.57B | $5.69B | $5.71B | $5.70B | $5.91B | $2.22B | $2.06B | $1.92B | $1.81B | $1.73B | $1.72B | $1.71B | $1.66B | $1.66B | $1.75B |
| Net Debt | $4.89B | $5.24B | $5.41B | $5.39B | $5.27B | $5.55B | $5.66B | $5.66B | $5.64B | $5.85B | $2.19B | $2.04B | $1.91B | $1.79B | $1.71B | $1.71B | $1.70B | $1.54B | $1.62B | $1.65B |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $-663.90M | $-282.08M | $40.69M | $66.66M | $72.19M |
| Depreciation and Amortization | $679.03M | $775.89M | $477.78M | $206.51M | $194.82M |
| Deferred Income Tax | $- | $- | $- | $-38.04M | $-48.20M |
| Stock Based Compensation | $31.82M | $14.29M | $20.35M | $10.73M | $9.92M |
| Change in Working Capital | $- | $-70.89M | $-32.81M | $-8.53M | $-851.00K |
| Accounts Receivables | $- | $- | $- | $- | $- |
| Inventory | $- | $- | $- | $- | $- |
| Accounts Payables | $- | $-18.77M | $24.19M | $9.43M | $2.07M |
| Other Working Capital | $-25.86M | $-52.12M | $-57.00M | $-17.96M | $-2.92M |
| Other Non Cash Items | $454.67M | $62.62M | $-233.26M | $-4.69M | $242.21M |
| Net Cash Provided by Operating Activities | $501.62M | $499.82M | $272.75M | $232.63M | $470.09M |
| Investments in Property Plant and Equipment | $- | $-231.03M | $-163.54M | $-100.69M | $-93.96M |
| Acquisitions Net | $- | $-3.82M | $1.06B | $-89.60M | $-65.66M |
| Purchases of Investments | $- | $- | $-564.68M | $-186.43M | $-268.36M |
| Sales Maturities of Investments | $- | $- | $1.20B | $682.00K | $23.85M |
| Other Investing Activities | $900.92M | $583.99M | $99.97M | $-186.43M | $-151.02M |
| Net Cash Used for Investing Activities | $900.92M | $349.14M | $1.63B | $-562.47M | $-555.17M |
| Debt Repayment | $-375.49M | $-404.16M | $-469.98M | $176.26M | $131.91M |
| Common Stock Issued | $104.00K | $130.00K | $22.90M | $331.12M | $142.00M |
| Common Stock Repurchased | $-519.30M | $-2.30M | $-3.19M | $-3.80M | $-1.44M |
| Dividends Paid | $-457.85M | $-472.24M | $-1.41B | $-175.46M | $-275.82M |
| Other Financing Activities | $-6.78M | $-5.65M | $-1.70M | $-405.00K | $103.06M |
| Net Cash Used Provided by Financing Activities | $-1.36B | $-884.22M | $-1.86B | $327.72M | $99.72M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- |
| Net Change in Cash | $43.22M | $-35.26M | $47.79M | $-2.13M | $14.65M |
| Cash at End of Period | $68.92M | $25.70M | $60.96M | $13.18M | $15.30M |
| Cash at Beginning of Period | $25.70M | $60.96M | $13.18M | $15.30M | $657.00K |
| Operating Cash Flow | $501.62M | $499.82M | $272.75M | $232.63M | $470.09M |
| Capital Expenditure | $- | $-231.03M | $-163.54M | $-100.69M | $-93.96M |
| Free Cash Flow | $501.62M | $268.79M | $109.20M | $131.94M | $376.13M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-108.21M | $-94.53M | $-145.94M | $-315.22M | $-41.90M | $-68.60M | $-83.73M | $-88.08M | $-36.28M | $28.62M | $6.13M | $42.23M | $21.61M | $-2.07M | $23.10M | $24.02M | $-15.86M | $8.23M | $75.51M | $4.32M |
| Depreciation and Amortization | $172.44M | $174.89M | $185.04M | $189.95M | $180.05M | $193.41M | $195.49M | $195.58M | $198.01M | $167.31M | $57.22M | $55.23M | $52.88M | $51.99M | $50.73M | $50.90M | $49.08M | $48.04M | $48.71M | $48.99M |
| Deferred Income Tax | $- | $- | $- | $- | $-58.36M | $9.79M | $48.57M | $- | $- | $- | $- | $- | $-13.98M | $9.67M | $-15.75M | $-17.98M | $21.81M | $-2.10M | $-68.08M | $178.00K |
| Stock Based Compensation | $16.97M | $7.91M | $3.38M | $3.56M | $3.13M | $2.55M | $3.92M | $4.99M | $3.57M | $9.72M | $3.36M | $3.70M | $2.55M | $2.54M | $2.63M | $3.02M | $2.47M | $2.44M | $2.40M | $2.60M |
| Change in Working Capital | $10.60M | $-9.23M | $35.23M | $-62.47M | $-21.55M | $-9.92M | $27.98M | $-67.41M | $8.86M | $-41.97M | $13.24M | $-12.95M | $361.00K | $3.86M | $3.62M | $-16.37M | $1.68M | $5.80M | $8.64M | $-16.97M |
| Accounts Receivables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-14.32M | $- | $- | $- |
| Inventory | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-87.98M | $- | $- | $- |
| Accounts Payables | $- | $- | $29.03M | $-52.16M | $13.29M | $6.54M | $28.35M | $-66.95M | $24.19M | $38.94M | $30.96M | $-34.13M | $18.18M | $-203.00K | $19.06M | $-27.61M | $2.07M | $- | $- | $-19.66M |
| Other Working Capital | $10.60M | $-9.23M | $6.20M | $-10.30M | $-34.83M | $-16.46M | $-370.00K | $-459.00K | $-15.33M | $-80.91M | $4.20M | $21.19M | $361.00K | $3.86M | $3.62M | $11.24M | $101.92M | $5.80M | $8.64M | $2.69M |
| Other Non Cash Items | $46.21M | $40.27M | $-4.80M | $-7.88M | $66.25M | $-9.05M | $-7.11M | $24.11M | $-28.08M | $-151.14M | $-1.52M | $-44.44M | $-1.04M | $-1.37M | $-1.20M | $-1.09M | $-645.00K | $243.91M | $-390.00K | $-668.00K |
| Net Cash Provided by Operating Activities | $138.01M | $119.30M | $168.15M | $76.15M | $127.32M | $118.18M | $185.13M | $69.19M | $146.09M | $12.54M | $70.35M | $43.77M | $62.37M | $64.63M | $63.13M | $42.50M | $58.52M | $306.32M | $66.80M | $38.44M |
| Investments in Property Plant and Equipment | $-62.24M | $-68.97M | $-67.39M | $-50.39M | $-74.16M | $-62.86M | $-33.85M | $-60.16M | $-65.75M | $-52.17M | $-22.30M | $-23.33M | $-31.04M | $-27.81M | $-21.90M | $-19.94M | $-31.26M | $-18.39M | $-22.15M | $-22.16M |
| Acquisitions Net | $- | $- | $- | $13.00K | $679.00K | $710.00K | $13.85M | $-3.82M | $9.78M | $1.10B | $-1.00K | $-49.60M | $-39.99M | $-4.59M | $-34.14M | $-10.88M | $- | $- | $- | $- |
| Purchases of Investments | $- | $- | $-25.93M | $-9.44M | $-24.50M | $-25.15M | $-25.21M | $-47.79M | $-67.16M | $-153.44M | $-312.34M | $-31.74M | $-81.78M | $-6.00K | $-98.06M | $-47.57M | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $303.27M | $1.25M | $334.65M | $205.91M | $11.36M | $149.51M | $331.28M | $762.93M | $81.75M | $26.79M | $36.78M | $-129.36M | $80.55M | $200.00K | $- | $- | $- | $- |
| Other Investing Activities | $481.01M | $399.73M | $-2.40M | $-16.00K | $-13.02M | $-1.91M | $-13.85M | $3.82M | $381.00K | $49.99M | $6.00K | $-40.34M | $-81.78M | $-6.00K | $-77.03M | $-39.01M | $-264.00M | $-107.10M | $-4.06M | $-86.03M |
| Net Cash Used for Investing Activities | $418.77M | $330.76M | $209.95M | $-58.56M | $236.68M | $118.61M | $-47.70M | $41.56M | $208.53M | $1.71B | $-167.90M | $-113.27M | $-197.80M | $-161.77M | $-133.07M | $-69.83M | $-295.26M | $-125.49M | $-26.22M | $-108.19M |
| Debt Repayment | $-306.35M | $-201.37M | $29.66M | $102.56M | $- | $-128.62M | $-31.61M | $-768.00K | $-229.76M | $-487.50M | $156.06M | $19.64M | $88.84M | $5.00M | $45.00M | $5.69M | $11.93M | $-1.15M | $-92.34M | $213.47M |
| Common Stock Issued | $- | $- | $- | $104.00K | $20.00K | $33.00K | $26.00K | $51.00K | $51.00K | $83.00K | $119.00K | $22.65M | $90.34M | $61.40M | $116.19M | $63.20M | $101.70M | $127.00K | $32.96M | $7.21M |
| Common Stock Repurchased | $-95.91M | $-150.02M | $-273.06M | $-318.00K | $-464.00K | $8.00K | $-113.00K | $-1.73M | $-2.30M | $-42.00K | $- | $-852.00K | $-1.79M | $- | $-55.00K | $-1.96M | $-544.00K | $- | $- | $-892.00K |
| Dividends Paid | $-109.79M | $-112.45M | $-117.35M | $-118.27M | $-118.07M | $-118.07M | $-118.05M | $-118.05M | $-117.98M | $-1.20B | $-47.01M | $-46.77M | $-44.63M | $-44.02M | $-44.02M | $-42.78M | $-40.82M | $-40.81M | $-40.51M | $-40.42M |
| Other Financing Activities | $-1.98M | $-1.84M | $-1.76M | $-1.20M | $-244.45M | $-1.38M | $-1.71M | $-1.27M | $-1.25M | $-13.20M | $- | $84.34M | $-153.00K | $133.43M | $-40.52M | $-27.00K | $-2.87M | $-39.00K | $32.58M | $-6.91M |
| Net Cash Used Provided by Financing Activities | $-514.03M | $-465.67M | $-362.51M | $-17.12M | $-362.96M | $-248.03M | $-151.46M | $-121.77M | $-351.24M | $-1.70B | $109.17M | $79.02M | $132.60M | $94.41M | $76.58M | $24.12M | $69.40M | $-41.88M | $-100.27M | $172.46M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $-251.75M | $131.30M | $120.44M | $- | $- | $- | $- | $- | $40.43M | $-68.14M | $50.60M | $-82.46M | $54.85M | $12.29M | $-81.78M | $81.14M |
| Net Change in Cash | $46.12M | $-18.96M | $15.59M | $473.00K | $1.03M | $-11.24M | $-14.04M | $-11.02M | $3.38M | $23.27M | $11.62M | $9.52M | $-2.83M | $-2.74M | $6.65M | $-3.22M | $-167.33M | $138.96M | $-59.69M | $102.71M |
| Cash at End of Period | $68.92M | $22.80M | $41.77M | $26.17M | $25.70M | $24.67M | $35.90M | $49.94M | $60.96M | $57.58M | $34.31M | $22.69M | $13.18M | $16.00M | $18.74M | $12.09M | $15.30M | $182.64M | $43.68M | $103.37M |
| Cash at Beginning of Period | $22.80M | $41.77M | $26.17M | $25.70M | $24.67M | $35.90M | $49.94M | $60.96M | $57.58M | $34.31M | $22.69M | $13.18M | $16.00M | $18.74M | $12.09M | $15.30M | $182.64M | $43.68M | $103.37M | $657.00K |
| Operating Cash Flow | $138.01M | $119.30M | $168.15M | $76.15M | $127.32M | $118.18M | $185.13M | $69.19M | $146.09M | $12.54M | $70.35M | $43.77M | $62.37M | $64.63M | $63.13M | $42.50M | $58.52M | $306.32M | $66.80M | $38.44M |
| Capital Expenditure | $-62.24M | $-68.97M | $-67.39M | $-50.39M | $-74.16M | $-62.86M | $-33.85M | $-60.16M | $-65.75M | $-52.17M | $-22.30M | $-23.33M | $-31.04M | $-27.81M | $-21.90M | $-19.94M | $-31.26M | $-18.39M | $-22.15M | $-22.16M |
| Free Cash Flow | $75.77M | $50.33M | $100.77M | $25.76M | $53.16M | $55.32M | $151.28M | $9.03M | $80.34M | $-39.63M | $48.05M | $20.45M | $31.33M | $36.82M | $41.23M | $22.56M | $27.27M | $287.93M | $44.64M | $16.28M |
Healthcare Realty Trust Dividends
Explore Healthcare Realty Trust's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
7.39%
Dividend Payout Ratio
-69.96%
Dividend Paid & Capex Coverage Ratio
1.10x
Healthcare Realty Trust Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.31 | $0.31 | March 03, 2025 | March 03, 2025 | March 19, 2025 | February 19, 2025 |
| $0.31 | $0.31 | November 12, 2024 | November 12, 2024 | November 27, 2024 | October 29, 2024 |
| $0.31 | $0.31 | August 12, 2024 | August 12, 2024 | August 28, 2024 | July 30, 2024 |
| $0.31 | $0.31 | May 10, 2024 | May 13, 2024 | May 23, 2024 | April 30, 2024 |
| $0.31 | $0.31 | February 23, 2024 | February 26, 2024 | March 14, 2024 | February 13, 2024 |
| $0.31 | $0.31 | November 13, 2023 | November 14, 2023 | November 30, 2023 | October 30, 2023 |
| $0.31 | $0.31 | August 14, 2023 | August 15, 2023 | August 30, 2023 | August 01, 2023 |
| $0.31 | $0.31 | May 15, 2023 | May 16, 2023 | June 02, 2023 | May 02, 2023 |
| $0.31 | $0.31 | March 06, 2023 | March 07, 2023 | March 21, 2023 | February 24, 2023 |
| $0.31 | $0.31 | November 14, 2022 | November 15, 2022 | November 30, 2022 | November 02, 2022 |
| $0.109 | $0.109 | August 12, 2022 | August 15, 2022 | August 30, 2022 | August 03, 2022 |
| $4.82 | $4.82 | July 21, 2022 | July 19, 2022 | July 27, 2022 | July 06, 2022 |
| $0.201 | $0.201 | July 13, 2022 | July 14, 2022 | July 19, 2022 | July 01, 2022 |
| $0.325 | $0.325 | July 05, 2022 | July 06, 2022 | July 15, 2022 | May 05, 2022 |
| $0.31 | $0.31 | May 13, 2022 | May 16, 2022 | May 27, 2022 | May 03, 2022 |
| $0.325 | $0.325 | April 01, 2022 | April 04, 2022 | April 11, 2022 | February 28, 2022 |
| $0.31 | $0.31 | February 25, 2022 | February 28, 2022 | March 15, 2022 | February 22, 2022 |
| $0.325 | $0.325 | January 03, 2022 | January 04, 2022 | January 11, 2022 | November 04, 2021 |
| $0.3025 | $0.3025 | November 12, 2021 | November 15, 2021 | November 30, 2021 | November 02, 2021 |
| $0.325 | $0.325 | October 01, 2021 | October 04, 2021 | October 11, 2021 | August 03, 2021 |
Healthcare Realty Trust News
Read the latest news about Healthcare Realty Trust, including recent articles, headlines, and updates.
Healthcare Realty Trust Announces Participation in Citi's 2025 Global Property CEO Conference and Provides Update on Rent Collection From Prospect Medical
NASHVILLE, Tenn., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) (“Healthcare Realty” or the “Company”) today announced that members of the Company's management team will participate in Citi's 2025 Global Property CEO Conference on March 3 – 4, 2025. The Company also published an updated investor presentation in advance of the conference and other upcoming investor meetings. The presentation is available at the Investor Relations section of the company's website at https://investors.healthcarerealty.com/corporate-profile/.
Healthcare Realty Trust: Lower Leverage, Repurchased Shares, And Under New Management
Rising interest rates and economic volatility have challenged REITs, with Healthcare Realty Trust facing significant financial difficulties and negative returns over the past decade. HR's strategic turnaround includes asset dispositions, share repurchases, and debt reduction, driven by new management and activist investor Starboard Value's influence. Operational improvements are evident with record leasing activity and NOI growth, but near-term dividend growth remains unlikely as focus shifts to deleveraging.
Healthcare Realty Trust Incorporated (HR) Q4 2024 Earnings Call Transcript
Healthcare Realty Trust Incorporated. (NYSE:HR ) Q4 2024 Earnings Conference Call February 19, 2025 11:00 AM ET Company Participants Ron Hubbard - Vice President of Investor Relations Constance Moore - Interim President and CEO Austen Helfrich - Chief Financial Officer Robert Hull - Chief Operating Officer Ryan Crowley - Chief Investment Officer Conference Call Participants Austin Wurschmidt - KeyBanc Capital Markets Juan Sanabria - BMO Capital Markets Nicholas Joseph - Citigroup Richard Anderson - Wedbush John Kilichowski - Wells Fargo Michael Gorman - BTIG Omotayo Okusanya - Deutsche Bank John Pawlowski - Green Street Nikita Bely - JPMorgan Operator Thank you for standing by.
Compared to Estimates, Healthcare Realty Trust (HR) Q4 Earnings: A Look at Key Metrics
The headline numbers for Healthcare Realty Trust (HR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Healthcare Realty Trust Reports Results for the Fourth Quarter and Announces Quarterly Dividend
NASHVILLE, Tenn., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the fourth quarter ended December 31, 2024. Net (loss) income attributable to common stockholders for the three months ended December 31, 2024 was $(106.8) million, or $(0.31) per diluted common share. Additionally, the Company announced its quarterly dividend of $0.31 per share and operating partnership unit.
Unlocking Q4 Potential of Healthcare Realty Trust (HR): Exploring Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Healthcare Realty Trust (HR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.
H&R REIT: How To Buy Apartments At A Double-Digit Discount
H&R REIT is one of Canada's cheapest REITs by price-to-FFO and price-to-NAV basis, but management and turnaround plans are questionable. Founded in 1996, H&R was a diversified REIT but faced challenges as investors preferred specialized REITs and internal issues arose. The 2021 turnaround plan aimed to exit retail and office segments, focusing on residential and industrial properties, but results have been mixed.
H&R Real Estate Investment Trust (HRUFF) Q4 2024 Earnings Call Transcript
H&R Real Estate Investment Trust (OTCPK:HRUFF) Q4 2024 Results Conference Call February 13, 2025 10:00 AM ET Company Participants Tom Hofstedter - Chief Executive Officer Larry Froom - Chief Financial Officer Emily Watson - Chief Operating Officer, Lantower Residential Division Conference Call Participants Matt Kornack - National Bank Financial Jimmy Shan - RBC Capital Markets Sumayya Syed - CIBC Operator Good morning, and welcome to H&R Real Estate Investment Trust 2024 Fourth Quarter Earnings Conference Call. Before beginning the call, H&R would like to remind listeners that certain statements, which may include predictions, conclusions, forecasts or projections in the remarks that follow may contain forward looking information, which reflect the current expectations of management regarding future events and performance and speak only as of today's date.
Healthcare Realty Trust Announces Fourth Quarter Earnings Release Date and Conference Call
NASHVILLE, Tenn., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced that it expects to report results for the fourth quarter of 2024 on Wednesday morning, February 19, 2025, before the market opens.
Healthcare Realty Trust: Growth In Outpatient Demand And Portfolio, Impacted By Net Losses
Healthcare Realty Trust gets an initial rating of hold, agreeing with the consensus today. Upside factors include macro data forecasting continued demand for outpatient care, and population growth in a key region for this REIT. The REIT has a strong tenant retention rate above 80%, and has been growing its property portfolio.
Fed Ahead
Ahead of the Federal Reserve's critical interest rate decision next week, U.S. equity markets snapped a three-week winning streak as benchmark interest rates jumped to the cusp of five-month highs. Lukewarm CPI and PPI inflation reports were "good enough" to solidify another Fed rate cut next week, but "sticky" trends called into question the outlook for continued easing in 2025. After setting a series of fresh record-highs in the prior week, the S&P 500 slipped 0.6% this week, but still remains on pace for its best year since 2019.
Healthcare Realty Trust Announces Key Leadership Changes
Austen Helfrich named permanent Executive Vice President and Chief Financial OfficerAndrew Loope will succeed John Bryant as Executive Vice President and General Counsel; Bryant to remain as Senior Vice President aAdsList.push('Article'); aAdsListSize.push([300, 250]); aAdsListCA.push(null); NASHVILLE, Tenn., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced key leadership changes. Austen Helfrich, who has served as Interim Chief Financial Officer since October 1, 2024, has been formally appointed as the Company’s permanent Executive Vice President and Chief Financial Officer, effective immediately. As part of a planned transition, Andrew Loope, Senior Vice President, Corporate Counsel and Secretary, will be promoted to Executive Vice President, General Counsel, and Secretary, succeeding John Bryant, effective January 1, 2025. Mr. Bryant will continue to serve as Executive Vice President and General Counsel through December 31, 2024, and will then remain with the Company in the role of Senior Vice President, Legal Affairs. “Healthcare Realty is fortunate to have someone of Austen’s talent and caliber ready to take on the role of permanent CFO. Since first joining Healthcare Realty in 2019, he has been instrumental in the formation and expansion of the Company’s joint venture program, including partnerships with Nuveen, CBRE Investment Management and KKR. His significant financial acumen and industry experience will be invaluable to the Company as we continue to drive long-term shareholder value,” said Constance “Connie” Moore, interim President and CEO.Moore continued, “Andrew Loope has been a trusted advisor to the Company since joining our legal department from the Waller Lansden (now Holland & Knight) law firm in 2008. John Bryant has dedicated more than 20 years of his professional career to Healthcare Realty. We are grateful for his many meaningful contributions as General Counsel and look forward to working closely with him and Andrew as they continue leading our legal team.”Ferguson Partners assisted the Board of Directors in the CFO search process. About Healthcare RealtyHealthcare Realty is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty’s portfolio includes nearly 675 properties totaling approximately 40 million square feet concentrated in 15 growth markets. Additional information regarding the Company can be found at www.healthcarerealty.com. Media Contacts:Charlie Koons / Craig SingerBrunswick GroupP; 212.333.3810 Investor Contact:Ron HubbardVice President, Investor RelationsP: 615.269.8290In addition to the historical information contained within, the matters discussed in this press release may contain forward-looking statements that involve risks and uncertainties. These risks are discussed in filings with the Securities and Exchange Commission by Healthcare Realty, including its Annual Report on Form 10-K for the year ended December 31, 2023 under the heading “Risk Factors,” and in its Quarterly Reports filed thereafter and in the Company’s other SEC filings. Forward-looking statements represent the Company’s judgment as of the date of this release. The Company disclaims any obligation to update forward-looking statements. Source: Healthcare Realty Trust Incorporated2024 GlobeNewswire, Inc., source Press Releases
Property Type Round-Up From REITworld 2024
REITs are poised for growth with stabilizing interest rates, low new supply, and robust balance sheets supporting higher rents and long-term asset growth. Healthcare REITs benefit from strong senior housing demand and limited new supply, despite valuation debates and management changes at Healthcare Realty. Multifamily and single-family rental sectors show regional variability, but long-term growth driven by demographic trends.
The State Of REITs: November 2024 Edition
The REIT sector snapped a 5-month winning streak with a -3.42% average total return in October. Micro cap (-2.04%) and mid-cap (-2.30%) REITs averaged modest declines in October, while large caps (-3.89%) and small caps (-4.62%) were deeper in the red. 72.90% of REIT securities had a negative total return in October.
2 High Yield REITs: Is The Thrill Of Victory Worth The Agony Of Defeat?
Chasing high yields can be dangerous; avoid “sucker yields” to protect your investments and ensure long-term financial safety. Sachem Capital Corp. has a history of dividend cuts and poor financial performance, making it a risky investment. Healthcare Realty Trust Incorporated faces management instability and unsustainable dividends, suggesting it is not a safe investment.
H&R Real Estate Investment Trust (HRUFF) Q3 2024 Earnings Call Transcript
H&R Real Estate Investment Trust (OTCPK:HRUFF) Q3 2024 Results Conference Call November 13, 2024 9:30 AM ET Company Participants Tom Hofstedter - Chief Executive Officer Larry Froom - Chief Financial Officer Emily Watson - Chief Operating Officer, Lantower Residential Division Conference Call Participants Sam Damiani - TD Cowen Mario Saric - Scotiabank Matt Kornack - National Bank Financial Jimmy Shan - RBC Capital Markets Operator Good morning, and welcome to H&R Real Estate Investment Trust 2024 Third Quarter Earnings Conference Call. Before beginning the call, H&R would like to remind listeners that certain statements, which may include predictions, conclusions, forecasts or projections, and the remarks that follow may contain forward-looking information, which reflect the current expectations of management regarding future events and performance and speak only as of today's date.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for HR.